Evidence map›Paper›PMID 39925360›Full record

ArticleHeliyon2025

Adverse outcome pathway-based assessment of pulmonary toxicity from the

Yoon Cho, Mi-Kyung Song, Dong Im Kim, Min-Seok Kim, Kyuhong Lee

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yoon ChoCenter for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, 30, Baekhak 1-Gil, Jeongeup-si, Jeonbuk-do, 56212, Republic of Korea.
Mi-Kyung SongCenter for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, 30, Baekhak 1-Gil, Jeongeup-si, Jeonbuk-do, 56212, Republic of Korea.
Dong Im KimCenter for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, 30, Baekhak 1-Gil, Jeongeup-si, Jeonbuk-do, 56212, Republic of Korea.
Min-Seok KimCenter for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, 30, Baekhak 1-Gil, Jeongeup-si, Jeonbuk-do, 56212, Republic of Korea.
Kyuhong LeeCenter for Respiratory Research, Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, 30, Baekhak 1-Gil, Jeongeup-si, Jeonbuk-do, 56212, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the increasing use of biocides globally and their widespread application in various formulations, the understanding of the toxicity of biocide mixtures remains limited. We previously identified cetylpyridinium chloride and dinotefuran as a potential binary biocidal combination associated with pulmonary fibrosis, based on two intersecting adverse outcome pathways (AOPs) using the molecular initiating events (MIE) modeling method and in vitro testing. These compounds activate or inhibit toll-like receptor 4 (TLR4) and peroxisome proliferator-activated receptor-gamma (PPAR-γ), which are associated with pathways having the potential to cause pulmonary fibrosis. In this study, we aimed to validate these AOPs by assessing the toxicity of cetylpyridinium chloride and dinotefuran mixture. Sixty C57BL/6 male mice were exposed to either dinotefuran or cetylpyridinium chloride or a mixture of the two via intratracheal instillation (ITI) to examine the synergistic effects of MIE and key events (KEs) within putative AOPs. Various parameters, including clinical and histopathological indicators, changes in body weight and organ weight, inflammatory cell distribution, and inflammatory cytokine expression in the bronchoalveolar lavage fluid (BALF), were analyzed. Additionally, key indicators such as TLR4, NF-κB, TNF-α were investigated to validate the mechanistic aspects of putative AOPs associated with pulmonary fibrosis. We observed significant changes in body weight and neutrophil count, recognized indicators of inflammation, along with inflammatory cell infiltrates, in the group exposed to the mixture of the two biocides. Moreover, increased levels of markers associated with epithelial-mesenchymal transition (EMT) and fibrosis (TNF-α, Acta2, IL-1β, and MMP9), as well as elevated levels of TGF-β, a common downstream signaling factor of TLR4 and PPAR-γ, were identified. Collectively, our findings highlight the potential toxic effects of a mixture of these two biocides in an in vivo model and confirmed the effective function of the putative AOP.

Indexed as

Adverse outcome pathway (AOP)BiocideCetylpyridinium chlorideDinotefuranMixture toxicity

Identifiers

PMID39925360
PMCPMC11804698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.